These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23866942)

  • 21. Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults.
    Dang C; Harrington KD; Lim YY; Ames D; Hassenstab J; Laws SM; Yassi N; Hickey M; Rainey-Smith S; Robertson J; Sohrabi HR; Salvado O; Weinborn M; Villemagne VL; Rowe CC; Masters CL; Maruff P;
    J Alzheimers Dis; 2018; 65(4):1313-1325. PubMed ID: 30149452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insomnia Moderates the Relationship Between Amyloid-β and Cognitive Decline in Late-Life Adults without Dementia.
    Xu W; Tan CC; Zou JJ; Cao XP; Tan L;
    J Alzheimers Dis; 2021; 81(4):1701-1710. PubMed ID: 33967043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease.
    Lim YY; Villemagne VL; Laws SM; Ames D; Pietrzak RH; Ellis KA; Harrington KD; Bourgeat P; Salvado O; Darby D; Snyder PJ; Bush AI; Martins RN; Masters CL; Rowe CC; Nathan PJ; Maruff P;
    Neurobiol Aging; 2013 Nov; 34(11):2457-64. PubMed ID: 23769397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL).
    Ellis KA; Szoeke C; Bush AI; Darby D; Graham PL; Lautenschlager NT; Macaulay SL; Martins RN; Maruff P; Masters CL; McBride SJ; Pike KE; Rainey-Smith SR; Rembach A; Robertson J; Rowe CC; Savage G; Villemagne VL; Woodward M; Wilson W; Zhang P; Ames D;
    Int Psychogeriatr; 2014 Apr; 26(4):543-54. PubMed ID: 24252258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations Between Microstructure, Amyloid, and Cognition in Amnestic Mild Cognitive Impairment and Dementia.
    Reas ET; Hagler DJ; Kuperman JM; Wierenga CE; Galasko D; White NS; Dale AM; Banks SJ; McEvoy LK; Brewer JB
    J Alzheimers Dis; 2020; 73(1):347-357. PubMed ID: 31796676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.
    Pietrzak RH; Lim YY; Neumeister A; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Restrepo C; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P;
    JAMA Psychiatry; 2015 Mar; 72(3):284-91. PubMed ID: 25629787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. White matter integrity determined with diffusion tensor imaging in older adults without dementia: influence of amyloid load and neurodegeneration.
    Kantarci K; Schwarz CG; Reid RI; Przybelski SA; Lesnick TG; Zuk SM; Senjem ML; Gunter JL; Lowe V; Machulda MM; Knopman DS; Petersen RC; Jack CR
    JAMA Neurol; 2014 Dec; 71(12):1547-54. PubMed ID: 25347157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention study.
    Clark LR; Racine AM; Koscik RL; Okonkwo OC; Engelman CD; Carlsson CM; Asthana S; Bendlin BB; Chappell R; Nicholas CR; Rowley HA; Oh JM; Hermann BP; Sager MA; Christian BT; Johnson SC
    Alzheimers Dement; 2016 Jul; 12(7):805-14. PubMed ID: 26806386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.
    Villemagne VL; Rowe CC
    J Alzheimers Dis; 2013; 33 Suppl 1():S349-59. PubMed ID: 22710919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of amyloid-β peptide functional brain networks in AD, MCI and HC.
    Jiang J; Duan H; Huang Z; Yu Z;
    Biomed Mater Eng; 2015; 26 Suppl 1():S2197-205. PubMed ID: 26405999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of β-Amyloid Burden With Sleep Dysfunction and Cognitive Impairment in Elderly Individuals With Cognitive Disorders.
    You JC; Jones E; Cross DE; Lyon AC; Kang H; Newberg AB; Lippa CF
    JAMA Netw Open; 2019 Oct; 2(10):e1913383. PubMed ID: 31617927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proper names from story recall are associated with beta-amyloid in cognitively unimpaired adults at risk for Alzheimer's disease.
    Mueller KD; Koscik RL; Du L; Bruno D; Jonaitis EM; Koscik AZ; Christian BT; Betthauser TJ; Chin NA; Hermann BP; Johnson SC
    Cortex; 2020 Oct; 131():137-150. PubMed ID: 32861209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma Amyloid-β Biomarker Associated with Cognitive Decline in Preclinical Alzheimer's Disease.
    Lim YY; Maruff P; Kaneko N; Doecke J; Fowler C; Villemagne VL; Kato T; Rowe CC; Arahata Y; Iwamoto S; Ito K; Tanaka K; Yanagisawa K; Masters CL; Nakamura A
    J Alzheimers Dis; 2020; 77(3):1057-1065. PubMed ID: 32925048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aβ amyloid, cognition, and APOE genotype in healthy older adults.
    Lim YY; Ellis KA; Ames D; Darby D; Harrington K; Martins RN; Masters CL; Rowe C; Savage G; Szoeke C; Villemagne VL; Maruff P;
    Alzheimers Dement; 2013 Sep; 9(5):538-45. PubMed ID: 23159043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between
    Hammers DB; Atkinson TJ; Dalley BC; Suhrie KR; Beardmore BE; Burrell LD; Horn KP; Rasmussen KM; Foster NL; Duff K; Hoffman JM
    Clin Neuropsychol; 2017 Apr; 31(3):531-543. PubMed ID: 28077020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenomenological characterization of memory complaints in preclinical and prodromal Alzheimer's disease.
    Buckley RF; Ellis KA; Ames D; Rowe CC; Lautenschlager NT; Maruff P; Villemagne VL; Macaulay SL; Szoeke C; Martins RN; Masters CL; Savage G; Rainey-Smith SR; Rembach A; Saling MM;
    Neuropsychology; 2015 Jul; 29(4):571-81. PubMed ID: 25664464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of anosognosia in alzheimer's disease and its relationship to amyloid.
    Hanseeuw BJ; Scott MR; Sikkes SAM; Properzi M; Gatchel JR; Salmon E; Marshall GA; Vannini P;
    Ann Neurol; 2020 Feb; 87(2):267-280. PubMed ID: 31750553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.